Aspen Aerogels (NYSE:ASPN) Upgraded by StockNews.com to “Sell” Rating

Aspen Aerogels (NYSE:ASPN) was upgraded by stock analysts at StockNews.com to a “sell” rating in a report issued on Wednesday.

Other equities research analysts have also issued reports about the stock. HC Wainwright reissued a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. TD Cowen increased their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. Roth Mkm reduced their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. Barclays dropped their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday. Finally, Piper Sandler reduced their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Stock Down 1.6 %

Aspen Aerogels stock traded down $0.26 during midday trading on Wednesday, reaching $15.54. The company’s stock had a trading volume of 2,504,477 shares, compared to its average volume of 1,586,966. Aspen Aerogels has a 52-week low of $9.57 and a 52-week high of $33.15. The stock has a market capitalization of $1.28 billion, a P/E ratio of 1,555.56 and a beta of 2.21. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.82. The stock’s 50-day simple moving average is $22.66 and its 200-day simple moving average is $24.74.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

Hedge Funds Weigh In On Aspen Aerogels

A number of large investors have recently bought and sold shares of ASPN. Point72 Hong Kong Ltd acquired a new stake in Aspen Aerogels in the second quarter valued at $84,000. nVerses Capital LLC purchased a new stake in Aspen Aerogels during the second quarter worth about $95,000. Quent Capital LLC acquired a new position in Aspen Aerogels during the third quarter worth about $118,000. Point72 DIFC Ltd purchased a new position in Aspen Aerogels in the second quarter valued at about $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new stake in shares of Aspen Aerogels during the 2nd quarter valued at approximately $145,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.